NBIX - Neurocrine Biosciences, Inc.
IEX Last Trade
127.06
-1.370 -1.078%
Share volume: 1,236,878
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$128.43
-1.37
-1.07%
View ratios
Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
Report Date | 2022-11-01 | 2023-02-09 | 2023-05-03 | 2023-08-01 | 2023-10-31 | 2024-02-09 | 2024-05-01 | 2024-08-01 | |
Total revenue | 387.900 M | 412.000 M | 420.400 M | 452.700 M | 498.800 M | 515.200 M | 515.300 M | 590.200 M | |
Cost of revenue | 6.100 M | 7.700 M | 8.500 M | 11.500 M | 11.200 M | 8.500 M | 7.500 M | 9.200 M | |
Gross profit | 381.800 M | 404.300 M | 411.900 M | 441.200 M | 487.600 M | 506.700 M | 507.800 M | 581.000 M | |
5.89% | 1.88% | 7.11% | 10.52% | 3.92% | 0.22% | 14.42% | |||
Operating expenses | 294.000 M | 300.900 M | 382.200 M | 367.600 M | 346.400 M | 356.400 M | 402.500 M | 433.100 M | |
Selling general and admin | 186.300 M | 182.900 M | 242.700 M | 221.800 M | 204.200 M | 218.900 M | 243.100 M | 242.000 M | |
Research and development | 107.700 M | 118.000 M | 139.500 M | 145.800 M | 142.200 M | 137.500 M | 159.400 M | 191.100 M | |
Total expenses | 300.100 M | 308.600 M | 390.700 M | 379.100 M | 357.600 M | 364.900 M | 410.000 M | 442.300 M | |
2.83% | 26.60% | -2.97% | -5.67% | 2.04% | 12.36% | 7.88% | |||
Operating income | 87.800 M | 103.400 M | 29.700 M | 73.600 M | 141.200 M | 150.300 M | 105.300 M | 147.900 M | |
Ebit | 87.800 M | 103.400 M | 29.700 M | 73.600 M | 141.200 M | 150.300 M | 105.300 M | 147.900 M | |
Pretax income | 97.900 M | 117.900 M | -103.300 M | 121.600 M | 115.600 M | 198.200 M | 34.500 M | 98.600 M | |
20.43% | -187.62% | -217.72% | -4.93% | 71.45% | -82.59% | 185.80% | |||
Income tax | 29.400 M | 28.900 M | -26.700 M | 26.100 M | 32.500 M | 50.500 M | -8.900 M | 33.600 M | |
Net income basic | 68.500 M | 89.000 M | -76.600 M | 95.500 M | 83.100 M | 147.700 M | 43.400 M | 65.000 M | |
29.93% | -186.07% | 224.67% | -12.98% | 77.74% | -70.62% | 49.77% | |||
Net income | 68.500 M | 89.000 M | -76.600 M | 95.500 M | 83.100 M | 147.700 M | 43.400 M | 65.000 M | |
29.93% | -186.07% | 224.67% | -12.98% | 77.74% | -70.62% | 49.77% |